
FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Davidson Kempner Capital Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor an
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Davidson Kempner Capital Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of
newsAcquisition Adds an Established Subscription-Based Food Commerce Business, Recurring Revenue Model and Proprietary Technology Platform to Tritent's Growing Portfolio LAS VEGAS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Tritent International Corp. (OTCID: TICJ) ("Tritent" or the "Company") today announced that its wholly owned Ontario subsidiary has entered into a definitive agreement to acquire 100% of the issued and outstanding shares of Super Fresh Foods Inc., owner and operator of AllYourMeals.com ,

BOSTON, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED (“ARCHIMED”), a leading investment firm focused exclusively on healthcare industries. Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools, said, “ARCHIMED brings deep healthcare and life sciences expertise, a strong understanding of the mark
WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that it has commenced an underwritten public offering of its common stock. In addition, the Company is expected to grant th
news/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- PesoRama Inc. (TSXV:PESO) (OTC:PSSOF) (FSE:ZE6) (“ PesoRama ” or the “ Company ”), a Canadian company operating dollar stores in Mexico under the JOi DOLLAR PLUS brand, is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter and sole bookrunner on behalf of itself and a syndicate of underwriters (collecti

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree
Agreement brings together RAYEL’s scientific foundation, KRTL’s U.S. commercialization strategy and expanding regulatory, API and research capabilities Lakewood, CO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") today announced that its wholly owned subsidiaries, KRTL International Corp. and KRTL Biotech Inc., have executed a definitive strategic partnership agreement with CENTRO DE INVESTIGACIONES QUIMICAS, S.R.L. ("CIQ") for the continued devel
newsST. CLOUD, Minn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI), a leading manufacturer of buses and motorcoaches and a provider of comprehensive aftermarket parts and service solutions, subsidiary New Flyer of America Inc. (New Flyer), today announced that Washington Metropolitan Area Transit Authority (“Metro”) has exercised its second-year options under a five-year contract for 500 buses. The order includes 75 Xcelsior ® hybrid-electric forty-foot

The type 2 diabetes market is expected to witness steady growth, driven by the rising global prevalence of diabetes, increasing rates of obesity and sedentary lifestyles, and growing awareness of early diagnosis and disease management. The expanding use of newer therapies, including GLP-1 receptor agonists, dual and triple incretin-based treatments, SGLT2 inhibitors, and other novel glucose-lowering agents, is further supporting market expansion. Additionally, the launch of emerging therapies su
Exton, PA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights, an independent market intelligence and advisory firm serving the global life sciences industry, today announced the launch of its Obesity Franchise. The launch brings Spherix’s existing obesity research into a focused franchise, connecting it with the firm’s established gastroenterology/MASH and nephrology/cardiorenal expertise while creating opportunities to expand its publication portfolio and advisory capabilities as treatm
newsDelray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a CAGR of 4.9% during the forecast period. Market growth is driven by the increasing emphasis on infection prevention and cross-contamination control, rising prevalence of chronic diseases, an aging population, growing surgical volumes, and expanding demand for long-term care, outpatient services, a

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- PesoRama Inc. (TSXV:PESO) (OTC:PSSOF) (FSE:ZE6) (“ PesoRama ” or the “ Company ”), a Canadian company operating dollar stores in Mexico under the JOi DOLLAR PLUS brand, is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter and sole bookrunner on behalf of itself and a syndicate of underwriters (collecti
Three-year award provides Xacta license maintenance, training and cyber services for Air Force ISR systems ASHBURN, Va., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced it has been awarded a three-year, $13.5 million contract by the 16th Air Force to provide continued support for U.S. Air Force Intelligence, Surveillance and Reconnaissance
newsMost tokens have no formal link to the business behind them: its IP, revenue and treasury usually sit in a separate entity. Umia places all three in one legal structure alongside the token, with treasury decisions made through onchain decision markets. NEW YORK , Oct. 5, 2026 -- Umia (umia.finance), the onchain platform for launching, funding and governing projects, today announced it has raised 6 million through the auction of UMIA, the first token launched through its own system. Ten funds and nearly 700 individual bidders took part in the seven-day sale, which ran on Base from August 26 to September 2 and opened with a three-day early round for vetted funds and zkTLS-verified community members. The public round then reached its cap seven minutes after opening on August 29, and the sale closed at more than 3x its 2 million minimum. Galaxy Ventures, DCG, Draper Associates, RenGen, Alpha EV, Maven 11 and Eon Capital were among the funds, all bidding on the same terms as every other participant, with no discounts.
Change has become a permanent part of doing business. Markets shift faster, customer expectations evolve, technology redraws competitive boundaries and established operating models face constant pressure. This edition examines how companies can approach reinvention through smarter processes, digital capability, product thinking and organizational flexibility. It explores why adaptation is no longer a response to crisis, but an ongoing discipline for businesses seeking relevance, resilience and sustainable growth.
Reinvention does not always require abandoning what already works. Often, it begins with understanding what must change, what should remain and where new capabilities can create meaningful value. In this edition, we look at business transformation as a continuous process shaped by technology, customers and changing markets, with an emphasis on practical thinking rather than fashionable disruption.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.